Abbott Introduces NeuroSphere Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S. Medical Device Investing
Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands Cannabis Investing News
Health Canada Approves KEYTRUDA® as First-line Treatment for Adults with Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer Pharmaceutical Investing
Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser Medical Device Investing
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI Biotech Investing
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir Pharmaceutical Investing
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy Biotech Investing
Abbott Receives FDA EUA for Laboratory PCR Assay That Detects and Differentiates SARS-CoV-2, Flu A, Flu B and RSV in One Test - and FDA EUA for Asymptomatic Usage of Alinity m COVID-19 Test Medical Device Investing
Regulatory approvals place Numinus lab at the forefront of global psychedelics research Cannabis Investing News
U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer Pharmaceutical Investing
